AI Drug Discovery in United Kingdom

This page covers the 1 AI drug discovery company in this directory that are headquartered in United Kingdom. That is 14% of the 7 AI drug discovery companies tracked across every country, which makes United Kingdom the 3rd-largest of the 3 national clusters in this category. Headquarters location matters for buyers who need contracting in a local legal entity, data residency inside United Kingdom, or overlapping working hours with an in-country delivery team — so the list below is filtered on stated headquarters, not on sales presence or reseller coverage.

Contracting notes specific to United Kingdom suppliers. UK vendors operate under the UK GDPR together with the Data Protection Act 2018, regulated by the Information Commissioner's Office rather than an EU supervisory authority. The consequence that matters most in an AI contract is transfers: a restricted transfer of personal data out of the UK to a country without a UK adequacy finding needs the ICO's International Data Transfer Agreement, or the UK Addendum bolted onto the EU Standard Contractual Clauses, and in either case a documented transfer risk assessment. The pre-Brexit EU SCCs stopped being usable for new UK transfer contracts on 21 September 2022, so any template still citing them is out of date. Ask a United Kingdom vendor which of the two mechanisms it signs, whether it has a transfer risk assessment on file, and where its model hosting and sub-processors actually sit.

Every entry is drawn from the same independently maintained AI drug discovery directory as the rest of the site. Placement is not sold, the order is alphabetical rather than ranked, and the listing is not auto-scraped. Where a field is unknown it is shown as unknown rather than filled with a guess, so you can see exactly how much is on the record for each United Kingdom provider before you contact them.

Prefer to compare without the country filter? Browse the full AI Drug Discovery directory or the wider AI company directory.